Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
FURX [NASD]
Furiex Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.98 Insider Own1.40% Shs Outstand10.61M Perf Week-8.27%
Market Cap798.30M Forward P/E148.99 EPS next Y0.51 Insider Trans55.47% Shs Float7.63M Perf Month-18.95%
Income-29.70M PEG- EPS next Q-0.63 Inst Own68.10% Short Float8.22% Perf Quarter73.36%
Sales71.00M P/S11.24 EPS this Y31.90% Inst Trans12.43% Short Ratio1.85 Perf Half Y72.93%
Book/sh1.79 P/B42.03 EPS next Y125.40% ROA-30.70% Target Price138.50 Perf Year125.95%
Cash/sh2.75 P/C27.34 EPS next 5Y- ROE-99.20% 52W Range32.01 - 121.97 Perf YTD79.10%
Dividend- P/FCF- EPS past 5Y-44.20% ROI-32.80% 52W High-38.31% Beta1.60
Dividend %- Quick Ratio1.60 Sales past 5Y31.00% Gross Margin- 52W Low135.05% ATR5.00
Employees24 Current Ratio1.60 Sales Q/Q42.40% Oper. Margin-34.40% RSI (14)31.69 Volatility6.61% 6.02%
OptionableYes Debt/Eq3.10 EPS Q/Q30.00% Profit Margin-41.80% Rel Volume0.59 Prev Close77.12
ShortableYes LT Debt/Eq2.52 EarningsMay 07 AMC Payout- Avg Volume338.81K Price75.24
Recom1.50 SMA20-13.27% SMA50-18.91% SMA20037.24% Volume199,354 Change-2.44%
04-Feb-14Reiterated Ladenburg Thalmann Buy $57 → $137
28-Jan-13Reiterated Ladenburg Thalmann Buy $33 → $38
28-Jan-13Initiated Canaccord Genuity Buy $45
14-May-12Reiterated Ladenburg Thalmann Buy $28 → $33
02-Mar-12Initiated Ladenburg Thalmann Buy $30
21-Oct-11Initiated Global Hunter Securities Buy $18
07-Apr-14 04:15PM  Furiex Pharmaceuticals Announces First Quarter 2014 Earnings Release and Conference Call Business Wire
03-Apr-14 04:23PM  Furiex Pharmaceuticals Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014 Business Wire
02-Apr-14 10:13AM  Best- And Worst-Performing Stocks YTD at Seeking Alpha
27-Mar-14 11:07AM  Furiex Pharmaceuticals Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiologys 63rd Annual Scientific Session Business Wire
20-Mar-14 01:04PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
18-Mar-14 04:29PM  Furiex Diarrhea Drug May Lure Takeover by Salix: Real M&A at Bloomberg
17-Mar-14 08:40AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report EDGAR Online
13-Mar-14 03:53PM  Trade-Ideas: Furiex Pharmaceuticals (FURX) Is Today's "Dead Cat Bounce" Stock at TheStreet
03:53PM  Trade-Ideas: Furiex Pharmaceuticals (FURX) Is Today's "Dead Cat Bounce" Stock
12-Mar-14 01:54PM  Furiex Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha -5.75%
01:54PM  Furiex Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript
11-Mar-14 05:13PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:30PM  Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results Business Wire
04:30PM  Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results
07:07AM  Q4 2013 Furiex Pharmaceuticals Inc Earnings Release - After Market Close CCBN
07-Mar-14 12:21PM  Furiex Pharmaceuticals Confirms Takedas Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes Business Wire
12:21PM  Furiex Pharmaceuticals Confirms Takedas Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes
19-Feb-14 07:01PM  3 Stocks Soaring Higher on These Drug Successes at Motley Fool
07:01PM  3 Stocks Soaring Higher on These Drug Successes
01:11PM  Drugmaker Furiex puts itself up for sale - Bloomberg Reuters
01:04PM  Drugmaker Furiex puts itself up for sale - Bloomberg Reuters
12:03PM  Furiex Said to Seek Buyer as Irritable Bowel Drug Meets Targets at Bloomberg
12:03PM  Furiex Said to Seek Buyer as Irritable Bowel Drug Meets Targets
11-Feb-14 06:30PM  Does Furiex Pharmaceuticals Inc Still Have Upside Potential? at Motley Fool
04:02PM  Furiex Pharma: What's The Best Plan Of Action? at Seeking Alpha
08:48AM  Can You Still Ride Last Month's 3 Best Stocks to Greater Gains? at Motley Fool
10-Feb-14 04:10PM  Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call Business Wire
08-Feb-14 10:00AM  The Best- And Worst-Performing Biotech Stocks, Jan. 31 to Feb. 7 at Forbes
09:02AM  3 Humongous Health-Care Stocks This Week at Motley Fool
07-Feb-14 09:58AM  With Recent Trial Results, Furiex Pharmaceuticals Still Has Significant Upside Potential at Seeking Alpha
06:00AM  Biotech Stock Mailbag: Furiex, La Jolla Pharma, Sarepta at TheStreet
05-Feb-14 01:29PM  Furiex Soars on Positive Eluxadoline Data Zacks +7.44%
01:12PM  2013's best hedge fund manager still picking winners at MarketWatch
09:29AM  Company news for February 05, 2014 Zacks
05:18AM  Strength Seen in Furiex Pharmaceuticals (FURX): Stock Shoots 129.9% Zacks
04-Feb-14 07:10PM  Why Furiex Pharmaceuticals Inc. Is an Instant Double at Motley Fool +129.91%
05:16PM  Why Furiex Pharmaceuticals, Lionbridge Technologies, and ATMI Are Today's 3 Best Stocks at Motley Fool
05:16PM  Why Furiex Pharmaceuticals, Inc. Shares Furiously Doubled at Motley Fool
04:44PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:03PM  Furiex price target raised to $137 from $58 at Ladenburg theflyonthewall.com
12:29PM  Furiex Pharmaceuticals Doubles, But Stock Is Now Fairly Priced at Wall St. Cheat Sheet
12:28PM  On The Fly: Midday Wrap at theflyonthewall.com
11:30AM  IBS Drug Success: The Fast and the Furiex at 24/7 Wall St.
11:30AM  IBS Drug Success: The Fast and the Furiex
10:09AM  Furiex treatment meets late-stage study goals AP
09:55AM  Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies at TheStreet
09:54AM  [video] Cramer's Six in 60: DIS, AAPL & more at CNBC
09:35AM  Furiex Shares Double as Irritable Bowel Drug Succeeds in Trials at Bloomberg
06:05AM  Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies at TheStreet
06:00AM  Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d Business Wire
06:00AM  Furiex irritable bowel syndrome drug succeeds in large trials Reuters
24-Dec-13 05:39AM  Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Jumps 8.9% Zacks
05:39AM  Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Jumps 8.9%
12-Dec-13 06:04AM  Corcept Therapeutics (CORT) Looks Good: Stock Moves 9.2% Higher Zacks
06:04AM  Corcept Therapeutics (CORT) Looks Good: Stock Moves 9.2% Higher
11-Dec-13 07:22AM  Zacks #1 Rank Additions for Wednesday Zacks
07:22AM  Zacks #1 Rank Additions for Wednesday
06-Dec-13 04:31PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits EDGAR Online
04:31PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
07:21AM  Zacks #1 Rank Additions for Friday Zacks
07:21AM  Zacks #1 Rank Additions for Friday
04-Dec-13 06:26AM  Zacks #1 Rank Additions for Wednesday Zacks
06:26AM  Zacks #1 Rank Additions for Wednesday
03-Dec-13 06:19AM  Can The Uptrend Continue for Furiex Pharmaceuticals Inc. (FURX)? Zacks
06:19AM  Can The Uptrend Continue for Furiex Pharmaceuticals Inc. (FURX)?
19-Nov-13 04:24AM  BioSpecifics Technologies (BSTC) Looks Good: Stock Moves 9.5% Higher Zacks
04:24AM  BioSpecifics Technologies (BSTC) Looks Good: Stock Moves 9.5% Higher
18-Nov-13 04:01AM  Strength Seen in Cadence Pharmaceuticals (CADX): Stock Soars 34% Zacks
04:01AM  Strength Seen in Cadence Pharmaceuticals (CADX): Stock Soars 34%
16-Nov-13 01:05PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
01:05PM  FURIEX PHARMACEUTICALS, INC. Financials
15-Nov-13 05:48AM  IGI Laboratories (IG) in Focus: Stock Surges 14.5% Zacks
12-Nov-13 07:53AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:06AM  Zacks #1 Rank Additions for Tuesday Zacks
06-Nov-13 01:40PM  Furiex Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha -5.63%
06:02AM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
05-Nov-13 04:07PM  Furiex Reports Third Quarter 2013 Financial Results Business Wire
07:07AM  Q3 2013 Furiex Pharmaceuticals Inc Earnings Release - After Market Close CCBN
04-Nov-13 04:26PM  RSI Alert: Furiex Pharmaceuticals (FURX) Now Oversold at Forbes
01-Nov-13 04:59PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
31-Oct-13 04:07PM  InPlay: Furiex Pharmaceuticals announces Priligy launch in the United Kingdom by Menarini; launch triggers $5.0 mln milestone payment Briefing.com
04:05PM  Furiex Pharmaceuticals Announces Priligy┬« Launch in the United Kingdom by Menarini Business Wire
28-Oct-13 05:18PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial S EDGAR Online
05:01PM  Furiex names Sailash Patel as CFO, effective November 15 theflyonthewall.com
05:01PM  InPlay: Furiex Pharmaceuticals announces the appointment of Sailash Patel to the position of Chief Financial Officer Briefing.com
05:00PM  Furiex Pharmaceuticals Announces Management Changes Business Wire
04-Oct-13 04:57PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin EDGAR Online
03-Oct-13 04:05PM  Furiex Pharmaceuticals Announces Third Quarter 2013 Earnings Release and Conference Call Business Wire
01-Oct-13 07:00AM  InPlay: Furiex Pharmaceuticals enters into a loan agreement for $15 mln and restructures its existing secured loan Briefing.com
07:00AM  Furiex Pharmaceuticals Enters into a Loan Agreement for $15 Million and Restructures Its Existing Secured Loan Business Wire
25-Sep-13 03:35PM  EU Nod for Furiex Diabetes Drugs Zacks
24-Sep-13 07:03AM  InPlay: Furiex Pharmaceuticals confirms Takeda (TKPYY) received European Marketing Authorization for VIPIDIA; MA triggers a $10 mln milestone payment to FURX Briefing.com
07:00AM  Furiex Confirms Takeda Receives European Marketing Authorization for VIPIDIA (alogliptin), VIPDOMET (alogliptin and metformin) and INCRESYNC (alogliptin and pioglitazone) Business Wire
03-Sep-13 07:03AM  InPlay: Furiex Pharmaceuticals confirms alogliptin cardiovascular safety outcomes trial (EXAMINE) met primary endpoint Briefing.com
07:00AM  Furiex Confirms Alogliptin Cardiovascular Safety Outcomes Trial (EXAMINE) Met Primary Endpoint Business Wire
15-Aug-13 01:04PM  FURIEX PHARMACEUTICALS, INC. Financials EDGAR Online Financials
12-Aug-13 02:13AM  Investors Are Digesting These Healthcare Stock Earnings Insights at Wall St. Cheat Sheet
08-Aug-13 04:15PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07-Aug-13 02:40PM  Furiex Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha -8.70%
06-Aug-13 05:25PM  FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
Furiex Pharmaceuticals, Inc. operates as a drug development company that is involved in compound development and collaboration activities primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company holds rights to royalties and regulatory and sales-based milestone payments for alogliptin, alogliptin combination products, and SYR-472 (trelagliptin) for the treatment of Type-2 diabetes, which are marketed under the Nesina and Liovel names in Japan, as well as under the Nesina, Oseni, and Kazano names in the United States. It also owns rights to royalties and sales-based milestones for Priligy (dapoxetine) for premature ejaculation, which is marketed in approximately 30 countries in Europe, the Asia-Pacific, and Latin America. In addition, the company holds license rights to eluxadoline (MuDelta), a novel, orally active, investigational agent, which is in Phase III development diarrhea-predominant irritable bowel syndrome, and to JNJ-Q2, a novel, fluoroquinolone antibiotic, which is in Phase III development for skin and lung infections. It markets its products through third party collaborators. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Almenoff June SheriePresidentFeb 04Option Exercise11.89115,1131,368,575139,713Feb 06 05:25 PM
Almenoff June SheriePresidentFeb 04Sale115.29115,11313,271,22124,600Feb 06 05:25 PM